Honoring Dr. John Najarian's legacy in organ transplants! $AKRO's new treatment for liver disease shows promise, potentially reducing the need for liver transplants. Phase 2 results are impressive, offering hope and a healthier path for patients. Exciting times for #Biotech! #LiverDisease #Innovation @jonnajarian @petenajarian #ITSNOTANOPTION